Find a Provider | Print Page | Contact Us | Report Abuse | Sign In | Register
Integrative Pain Care Policy Congress
Blog Home All Blogs
Welcome to the Integrative Pain Care Policy Congress Blog!

Brought together by their collective agreement that comprehensive integrative pain management is the best approach to caring for people with pain, and that none of us can properly advance this kind of care alone, the Integrative Pain Care Policy Congress is made up of leaders from more than 50 organizations (and growing!) representing the full scope of licensed and certified health care providers, public and private payers, policy experts, and pain research and patient advocacy organizations.

Are you or your organization interested in joining the Policy Congress, or would you like to receive email updates when this blog is updated? Contact Amy Goldstein for more information.

 

Search all posts for:   

 

Guest Post: Oregon Makes a Bad Proposal to “Fix” the Opioid Problem

Posted By Bob Twillman, Ph.D., FACLP, Executive Director, Academy of Integrative Pain Management, Tuesday, July 31, 2018

As I’ve said many times, to solve the complex problems of opioid misuse and overdose, policymakers across the country are blindly and blithely reaching for the simplest solutions. Typically, these solutions focus on reducing opioid prescribing to--or beyond--the bare minimum. Because these policies often are enacted with very little forethought and very little concern for the unintended consequences, policymakers sometimes unhappily discover after the fact that they may not have solved the original problem, but instead, have created a new one that may be even worse. This “ready, fire, aim” approach to policymaking, is, I fear, what we are facing now in Oregon, and we’re not going to sit idly by while it happens.

Currently, Oregon’s Health Evidence Review Commission (HERC), through its Value-based Benefits Subcommittee (VbBS), is considering a policy proposal from the state’s Chronic Pain Task Force that would deny coverage of opioids for most chronic pain conditions beyond 90 days, mandate the taper and discontinuation of opioid therapy for patients currently receiving it, and instead cover only a variety of non-opioid treatments for people living with long-term pain. While AIPM strongly supports increased use of nonpharmacological treatments and educates practitioners on the benefits of an integrative approach to treating pain, we are gravely concerned with the access to care issues that would be implicated if this policy were to be adopted as it is written.

This policy proposal will apply to all Oregon Medicaid patients diagnosed with conditions of the back and spine, and with chronic pain, except those who qualify for palliative care. Under the current proposal, between six weeks and 90 days, the use of opioids will only be allowed if several conditions are met, including that they must be prescribed in conjunction with therapies such as spinal manipulation, physical therapy, yoga, or acupuncture. What’s more, no opioids whatsoever will be covered after 90 days except for purposes of tapering a patient down to 0 MME/day within one year, regardless of how a patient’s pain and function respond to the taper.

Given that AIPM’s top priority is advancing access to integrative pain care, it would be easy to assume that we would support this policy change—we do not.

Health care providers treating patients living with complex pain conditions need access to all the tools in the toolbox, including both opioid and non-opioid medications, and non-pharmacological treatments. While we focus on removing barriers to non-pharmacological treatments that have not, to date, been adequately covered, we also have to be vigilant to prevent the erection of new barriers that block our access to tools that have been fully available. While some ratcheting back of opioid prescribing for chronic pain is not only appropriate but necessary, it should not be an all-or-none proposition. Despite the scarcity of randomized controlled trials of the long-term efficacy of opioids (which, by the way, is the same scarcity of RCTs we face with non-opioid treatments for pain), we know from clinical experience that there are some people with chronic pain who do well on long-term opioid therapy, and whose quality of life is likely to be markedly diminished if this policy goes into effect.

We have three major concerns with this proposed policy:

  1. Despite hinging access to opioid treatment on use of one of more non-opioid therapies, the Oregon proposal makes no plan for ensuring that the covered non-opioid therapies are geographically accessible to patients, or that there is a sufficient supply of providers for these therapies. See AIPM’s letter related to access to care concerns.
  2. The proposed changes do not mention what action should be taken if the patient begins to experience clinically significant increases in pain and decreases in function upon tapering the opioid dose. Appropriate medical care requires that a taper to be paused, stopped, and possibly reversed, based on documentation of detrimental changes to the patient’s functioning resulting from the taper. See AIPM’s letter related to forced opioid tapering.
  3. The Oregon proposal is unsupported by current treatment guidelines related to opioid prescribing, including those issued by the Centers for Disease Control and Prevention (CDC) in 2016, Canada in 2017, the U.S. Veteran’s Administration, and professional medical associations. See the sign-on letter that I joined on behalf of AIPM.

While it was recommended that all comments for the August 9th meeting of HERC/VbBS be in by July 30 to ensure sufficient time for them to be considered, comments will still be accepted up until August 7th. Comments must be no longer than 1000 words and can be submitted to herc.info@state.or.us.

*     *     *

Update 8/10/2018

Dr. Twillman testified at the in-person meeting of HERC/VbBS on August 9, 2018. See his testimony related to forced opioid tapering and the need for any taper plan to contain a provision allowing that taper to be paused, stopped, and/or reversed if lower doses are associated with poorer function.

This post has not been tagged.

Share |
PermalinkComments (0)
 

Guest Post: Physical Therapists Offer a Comprehensive Strategy to Combat the Opioid Crisis

Posted By Kara Gainer, JD and Kate Gilliard, JD, American Physical Therapy Association, Friday, July 13, 2018

With the on-going public health crisis resulting from misuse and addiction to prescription opioids, more and more groups are seeking to identify and pursue solutions that address the crisis, including increasing patient and physician knowledge about different strategies to manage pain. The American Physical Therapy Association (APTA), a participant of the Academy of Integrative Pain Management’s Integrative Pain Care Policy Congress, continues to advocate for increased access to safe and effective nonpharmacological approaches to pain management.

To further these efforts, APTA’s website contains a comprehensive advocacy strategy for promoting safe pain management as well as a number of tools and resources for physical therapists and other health care professionals to use to advance person-centered care with multidisciplinary approaches that include physical therapy and other safe nonpharmacological treatment options. Highlights include a newly released white paper reviewing how opioid-centric solutions to dealing with pain have led to widespread misuse and addition. The paper highlights the valuable role of physical therapy in improving patient outcomes and altering the trajectory of the existing public health crisis. APTA’s position paper for federal advocacy provides a 3-point strategy to combat the crisis:

  1. Integrated Team Approach
    Public and private health plans should include benefit design, reimbursement models, and integrated team approaches that support early access to nonpharmacological interventions for the primary care treatment of pain.
  2. Early Access to Conservative Care
    Public and private health plans should reduce or eliminate copays and other policy barriers to care to increase access to person-centered nonpharmacological pain treatments and interventions.
  3. Education for Primary Care Providers and the General Public
    Primary care providers should have access to information on the value of nonpharmacological, person-centered interventions and how to appropriately assess, treat, and inform patients with pain.

In addition to its policy objectives, APTA’s #ChoosePT campaign educates the public about their options to manage pain. The campaign’s goal is to raise awareness about the benefits of treatment options that follow guidelines established by the Centers for Disease Control and Prevention (CDC). These options include alternatives like physical therapy.

APTA’s work complements the Integrative Pain Care Policy Congress in seeking solutions based on comprehensive integrative pain management and individualized care for people with pain. To learn more about APTA and its advocacy efforts to increase access to and awareness of nonpharmacological pain-management treatments, including physical therapy, visit the association’s website Advocating for Safe Approaches to Pain Management.

This post has not been tagged.

Share |
PermalinkComments (0)
 

Newly Passed Laws Increase Access to Integrative Pain Management

Posted By Katie Duensing, Wednesday, July 11, 2018

Similar to other chronic conditions like diabetes and high blood pressure, chronic pain isn’t typically cured, but is managed with a combination of therapies and approaches specific to the individual.  However, if you’re at all familiar with the current state of pain management in the United States, you already know that this kind of interdisciplinary integrative pain care is uncommon—in part because services other than traditional allopathic medical care are often poorly reimbursed and in part because these services are often in short supply in rural and other underserved areas. 

Recently, in an effort to optimally treat the 100 million Americans living with pain while reducing the prescription drug overdose epidemic, policymakers are beginning to truly understand the urgent need to ease access to alternative forms of treatment, including chiropractic care, physical therapy, massage therapy, and more.  During the 2017-2018 legislative sessions, we have witnessed an encouraging new trend: bills to advance comprehensive, integrative pain management are finally passing!

United States – In relevant part, the National Defense Authorization Act for Fiscal Year 2018 directs the Secretary of Defense to conduct a study on the effectiveness of the training provided to military health care providers regarding opioid prescribing practices. In doing so, the Secretary of Defense shall, in part, consider the feasibility and advisability of further strengthening opioid prescribing practices by means of developing methods to encourage health care providers of the Department to use physical therapy or alternative methods to treat acute or chronic pain.

LouisianaSenate Bill 285 (2018) prohibits a health insurance issuer from denying a non-opioid prescription in favor of an opioid prescription when prescribed for chronic pain. Effective August 1, 2018, it shall be unlawful for an insurer to deny a prescribed medication and attempt to substitute an alternative medication that requires any of the following:

  1. An increased number of pills per prescription.
  2. A higher Drug Enforcement Administration schedule medication than the one prescribed.
  3. The substitution of an extended release medication that does not have defined abuse deterrent properties for a prescription of a medication that does have defined abuse deterrent properties.

Maine – In March 2018, overriding the Governor’s veto, the legislature passed LD 1030 (2017), An Act to Require Health Insurance Coverage for Covered Services Provided by Naturopathic Doctors. A carrier offering a health plan in this Maine shall provide coverage for health care services performed by a licensed naturopathic doctor when those services are covered services under the health plan when performed by any other health care provider and when those services are within the lawful scope of practice of the naturopathic doctor. The law also institutes requirements related to deductible and co-pay limits and network participation. See AIPM’s letter of support (note: the bill was unfortunately amended after this letter was written—it had started as a non-discrimination bill that would have applied to all health care services, not just naturopathic doctors).

MissouriHouse Bill 1516 (2018) states that MO HealthNet shall, subject to appropriation, cover up to twenty visits per year for services limited to examinations, diagnoses, adjustments, and manipulations and treatments of malpositioned articulations and structures of the body provided by licensed chiropractic physicians practicing within their scope of practice. See AIPM’s letter of support for the companion bill, SB 597.

TennesseeSB 2155 (2018), which took effect July 1st, specifies that in developing or implementing any payment reform initiative involving the use of episodes of care with respect to medical assistance provided by the bureau of TennCare or the health care finance and administration (HCFA), the bureau and the HCFA shall exclude charges related to pain relief that decreases the use of opioids from the calculation of costs for any episode of care. 

WashingtonSenate Bill 5779 (2017) states that “Health transformation in Washington state requires a multifaceted approach to implement sustainable solutions for the integration of behavioral and physical health.” The legislation concerns behavioral health integration in primary care, requiring a complete review of payment codes available to health plans and providers related to primary care and behavioral health, including adjustments to payment rules if needed to facilitate bidirectional integration.

Finally, there are two important bills just shy of passage:

Delaware – The legislature sent Senate Bill 225 (2018) to the Governor on June 30, 2018. The bill awaits action from the Governor. This bill would prohibit numerical limits on physical therapy and chiropractic care and would ensure that practitioners understand when these treatments are indicated for particular patients by adding continuing education requirements for prescribers relating to risks of opioids and alternatives to opioids. The bill also creates a pilot program within the state employee health care plan that allows the use of massage therapy, acupuncture, and yoga for the treatment of back pain. See the letter of support from AIPM and US Pain Foundation.

VermontSenate Bill 224 (2018), as introduced and passed by the Senate, allows health insurers to subject health care services provided by a chiropractic physician to co-payments, but only so long as those co-payments are not greater than the amount of the co-payment applicable to care and services provided by a primary care provider under the plan.  However, the House dramatically amended the bill prior to passage, so the bill must go to Conference Committee before reaching the Governor. See the letter of support from AIPM for the as-introduced version of the bill.

This post has not been tagged.

Share |
PermalinkComments (0)
 

AHRQ, NIH, HHS, CMS & Congress: Looking to Integrative Pain Care to Reduce Opioid Use

Posted By Katie Duensing, Tuesday, June 19, 2018

Agency for Healthcare Research and Quality (AHRQ) released Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review. The evidence-based Practice Center Program at AHRQ found that interventions that improved function and/or pain for certain conditions (such as low back pain, neck pain, knee and hip osteoarthritis, fibromyalgia, and tension headache) included spinal manipulation, acupuncture, cognitive behavioral therapy, massage, multidisciplinary rehabilitation, and more. While long-term evidence was sparse, there was no evidence suggesting serious harms from any of the interventions studied.

National Institutes of Health (NIH) leadership outlines the interdisciplinary research plan for the HEAL Initiative. Launched in April 2018, the HEAL Initiative is a trans-NIH effort to advance national priorities in addressing the opioid crisis through science with a focus on two primary areas: (1) improving treatments for opioid misuse and addiction, and (2) enhancing strategies for pain management. In part, critical components of the HEAL research plan include:

  • Supporting discovery and development of targets for non-addictive pain management, and therapies to treat those targets.
  • Collecting data to determine what factors lead acute pain to transition to chronic pain and how to block that transition.
  • Partnering with public and private groups to test effective treatments for pain and addiction using HEAL’s clinical trial networks.

The Pain Management Best Practices Inter-Agency Task Force held its first meeting from May 30-31 and received over 2,500 written comments. Created by Section 101 of the Comprehensive Addiction and Recovery Act of 2016 and administered by the Department of Health and Human Services, the Task Force is to identify (and propose solutions to) gaps or inconsistencies between best practices for pain management developed or adopted by Federal agencies. Following the initial meeting, three subcommittees were formed to further investigate:

  1. Medication; physical therapy; surgical and minimally invasive procedures;
  2. Psychological approaches; risk assessment; stigma;
  3. Complementary and alternative medicine; access to care; and, education.

Center for Medicare & Medicaid Services (CMS) released their Roadmap to Address the Opioid Epidemic. Related to the area of prevention, the roadmap encourages prescribers to manage pain using a safe and effective range of treatment options that rely less on prescription opioids. While the roadmap claims that significant progress has been made in identifying overprescribing patterns, it also acknowledges that CMS must build on these efforts by promoting effective, non-opioid pain treatments by identifying and developing solutions for treatment barriers that prevent people from accessing non-opioid pain treatments across Medicare, Medicaid, and private insurance plans.

Congress continues to consider scores of bills related to pain management, opioids, and substance use disorder.

This post has not been tagged.

Share |
PermalinkComments (0)
 

Guest Post: How Policymakers Can Redefine Pain Management

Posted By Institute for Patient Access, Monday, June 18, 2018

More than 42,000 Americans died from an opioid overdose in 2016. Meanwhile, millions of other Americans suffer from chronic pain. The situation poses a difficult question for policymakers: How do we meet the needs of pain patients without contributing to the national opioid crisis?

A newly released white paper from the Alliance for Balanced Pain Management offers some suggestions.  

In “Redefining Pain Management,” the group outlines five policy strategies for striking a balanced approach.

  1. Improve access to abuse-deterrent technology. “For many patients, opioids are still an effective and appropriate pain treatment,” the paper notes. Opting for abuse-deterrent formulations where appropriate can minimize the risk for household, family and community alike.  Abuse-deterrent formulations, which have been shown to reduce diversion by nearly 91 percent, are designed to resist crushing or dissolving for recreational use.
  2. Increase availability of balanced pain management. Balanced pain management can treat pain and decrease the need for opioids by offering more options for physicians and patients.  The approach includes treating chronic pain with integrated care, which might include physical or occupational therapy, chiropractic care, talk therapy and other approaches.  It also includes multimodal analgesia, an approach to acute pain that uses two or more techniques to reduce pain.
  3. Enable technology-based solutions. “Technology-based solutions also play a role in combating opioid abuse and overdose,” the white paper explains.  The paper notes that the Food and Drug Administration has approved more than 200 medical devices to help treat pain.  These include devices such as intraspinal infusion pumps, which reduce the amount of opioid needed by delivering the medication directly to the spinal cord, and neurostimulation, which disrupts pain signals to the brain.
  4. Encourage innovation on non-addictive pain treatments. Public policies can encourage a balanced approach to pain management.  The paper points to the Department of Health and Human Services’ Five-Point Opioid Strategy and the 2017 Integrative Pain Care Policy Congress as examples.
  5. Ensure stronger coverage policies. The paper notes that health plan design influences which pain management options patients and health care providers have at their disposal.  For integrative treatment and technology-based solutions to impact the opioid crisis, the paper explains, they must be accessible.

To learn more, read the Alliance for Balanced Pain Management’s “Redefining Pain Management.”

Note: This blog first appeared on the Institute for Patient Access Policy Blog.

This post has not been tagged.

Share |
PermalinkComments (0)
 

Pain Management and Opioids Continue to Dominate the Federal Discussion

Posted By Katie Duensing, Wednesday, May 23, 2018

The inaugural meeting of the Pain Management Best Practices Inter-Agency Task Force (required under Section 101 of the Comprehensive Addiction and Recovery Act of 2016) will be held on Wednesday, May 30, from 9:30 a.m. to 5:00 p.m., and Thursday, May 31, from 9:00 a.m. to 3:30 p.m., in the Hubert H. Humphrey Building, 200 Independence Avenue, S.W., Washington, D.C. This meeting will consist of the swearing in of the Task Force members, an overview of various topics surrounding pain management, and the establishment of the Task Force subcommittees.  Members of the public will have an opportunity to provide up to three minutes of oral testimony at the meeting on May 30th from 11:40 a.m. to 12:10 p.m., and on May 31st from 1:50 p.m. to 2.20 p.m. Individuals are also welcome to submit their written comments by Friday, May 25th.

Caring for our Military: Considering Non-drug Therapies for Pain, a lecture hosted by the National Center for Complementary and Integrative Health, will be held on Monday, June 4th on the NIH main campus, Building 10, Lipsett Amphitheater, and will also be available via live videocast. This lecture is the second in NCCIH’s Integrative Medicine Research Lecture Series, which aims to provide overviews of the current state of research and practice involving complementary health approaches and explores perspectives on the emerging discipline of integrative medicine.

FDA will hold a public meeting on Patient-Focused Drug Development on Chronic Pain on Monday, July 9th from 10:00 a.m. to 4:00 p.m. The public meeting will provide patients (including adult and pediatric patients) with an opportunity to present to FDA their perspectives on the impacts of chronic pain, views on treatment approaches for chronic pain, and challenges or barriers to accessing treatments. FDA is particularly interested in hearing from patients who experience chronic pain that is managed with analgesic medications such as opioids, acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), antidepressants; other medications; and non-pharmacologic interventions or therapies. Electronic comments will be accepted until September 10, 2018.

Congress continues to work on a large number of bills related to opioids and pain management, including a number that would increase access to comprehensive, integrative pain management. On May 17th, the House Energy and Commerce Committee advanced 32 bills to the full House for a vote. Included in the bills advanced were bills adjusting payments to encourage non-opioid drugs for post-surgical pain management (HR 5809) and injections (HR 5804) and a bill related FDA guidance on non-addictive pain treatments (HR 5806). On May 16th, the House Ways and Means Committee advanced seven bills related to opioids, one of which (HR 5723) requires that by March 15, 2019 the Medicare Payment Advisory Commission (MedPAC) report to Congress on: Medicare payment for pain management treatment options in a hospital setting; incentives under Medicare hospital payment for prescribing opioids relative to non-opioid alternatives; and tracking and monitoring of opioid use through Medicare claims.

This post has not been tagged.

Share |
PermalinkComments (0)
 

Guest Post: How Behavioral Conditions Worsen Chronic Pain

Posted By Omar Manejwala, M.D., Wednesday, April 25, 2018


We have no right to help one set of patients while harming another.  With media attention on the opioid overdose crisis and widespread efforts to reduce opioid prescribing implemented across systems of care, there is a real risk that people who are suffering from chronic pain are being forgotten—or worse—vilified.  In the chaos of competing ideas about how to address these twin crises, the Academy of Integrative Pain Management launched an ambitious effort—a “policy congress” in October 2017 that invited the ideas and active participation of the major stakeholders—even including those experiencing chronic pain themselves.  The group was tasked to answer one question: what is comprehensive integrative pain management?  This deceptively simple question led to several more.  Is it medical or psychological?  What is the role of spirituality in recovery?  What about complementary approaches?

Among other areas of consensus, policy congress participants generally seemed to agree with the idea that behavioral drivers play a key role.  In my recent article, How Behavioral Conditions Worsen Chronic Pain, I explore how behavioral conditions worsen chronic pain and how we might better integrate behavioral healthcare in our approaches to managing this challenging condition. 

Read the full article here.

Omar Manejwala, M.D. is a psychiatrist and the Chief Medical Officer of Catasys.

This post has not been tagged.

Share |
PermalinkComments (0)
 

Interest, Funding, and Legislation Related to Integrative Pain Care Abounds

Posted By Katie Duensing, Thursday, April 19, 2018

Interest in comprehensive, integrative pain management continues to skyrocket. In the past month, we have seen many related opportunities arise that have the potential to truly shift the state of pain care in the United States.

Helping clinicians to understand the need to utilize comprehensive, integrative pain management

The National Center for Complementary and Integrative Health has announced the NCCIH Integrative Medicine Research Lecture Series. The first two lectures will be:

  • Reframing the Primary Care Management of Chronic Pain on April 23rd
  • Caring for our Military: Considering Non-drug Therapies for Pain on June 4th

Improving government funding for pain research

The National Institute on Drug Abuse and National Center for Complementary and Integrative Health have announced a funding opportunity titled Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain. The purpose of this initiative is to encourage research that investigates the role of epigenetic or non-coding RNA regulatory pathways in the development, maintenance, or treatment of chronic pain, ultimately providing foundational knowledge that can be used to develop novel and non-addictive pain medications or to develop biomarkers that predict chronic pain progression or treatment response. 

The National Institutes of Health has launched the HEAL Initiative. Toward this effort, NIH is nearly doubling funding for research on opioid misuse/addiction and pain from approximately $600 million in fiscal year 2016 to $1.1 billion in fiscal year 2018. In part, the initiative will: define and support best practices for pain management using nondrug and integrated therapies for specific pain conditions; pursue public-private partnerships to develop new non-addictive pain medicines; and, launch a longitudinal study to follow patients 1) after acute onset of musculoskeletal pain, and 2) after surgery to identify biomarkers that might predict which individuals are more likely to transition from acute to chronic pain.

Moving legislation forward to improve coverage of integrative care

The ACE Research Act (HR 5002/S 2406) aims to provide NIH with the necessary tools and flexibility to support innovative medical research. It would enable the Director of NIH to more quickly and efficiently support research on new, non-addictive treatments for pain. Further, NIH will be able to more easily partner with innovative companies with cutting-edge technology to address the opioid overdose epidemic and other public health concerns. Multiple members of the Integrative Pain Care Policy Congress recently signed on in support of this bill.

Many state legislatures are currently considering legislation that would improve coverage of comprehensive, integrative pain management. You can find pain-related legislation sorted by state and by issue in AIPM’s legislation trackers. Some of the many bills of interest include:

  • RI S 2537, an act that would require health insurers to provide coverage for physical therapy, occupational therapy, massage therapy, and the healing art of acupuncture and oriental medicine. 
  • VT S 224, an act that would allow health insurers to subject health care services provided by a chiropractic physician to co-payments, but only so long as those co-payments are not greater than the amount of the co-payment applicable to care and services provided by a primary care provider under the plan. 
  • MO SB 597, an act that would expand MO HealthNet payments to include up to twenty (20) visits per year for services limited to examinations, diagnoses, adjustments, and manipulations and treatments of malpositioned articulations and structures of the body provided by licensed chiropractic physicians practicing within their scope of practice. 
  • NY SB 5764, an act that would prohibit insurers from imposing co-payments for physical or occupational therapy greater than the co-pay for similar services provided by a physician.

This post has not been tagged.

Share |
PermalinkComments (0)
 

New Workgroups to Advance Comprehensive, Integrative Pain Care Beginning in April!

Posted By Katie Duensing, Thursday, March 29, 2018

As a result of feedback from the participants of the Integrative Pain Care Policy Congress, we are beginning three new workgroups to implement focused action steps to advance comprehensive, integrative pain care and address our nation’s challenges with pain, opioid misuse, and mental health.  Below you will find a summary of each workgroup’s first goal, the co-facilitators, and the monthly meeting schedules. If you are interested in participating in one of these workgroups and have not yet signed up, please contact Amy Goldstein.

Addressing Coverage & Constraints.  This workgroup will begin with a comprehensive analysis of policy and coverage issues as they apply to pain care.  Co-facilitators are Ravi Prasad, PhD, Associate Chief, Stanford University Division of Pain Medicine; and Doug Metz, DC, EVP & Chief Services Officer, American Specialty Health.

A concept outline will be shared in advance of the first meeting to be held on Tuesday, April 17, 2018 from 7-8AM PST / 8-9AM MST / 9-10AM CST / 10-11AM EST.  Monthly meetings will occur at the same time on the 3rd Tuesday of each month.

View the roster of participants for Addressing Coverage & Constraints.

Promoting Comprehensive, Integrative Pain Care. This group will begin with an analysis of successful models of comprehensive, integrative pain care, looking for common components that will inform future goals related to expanding access to this type of care.  Co-facilitators are Steve Stanos, DO, President, American Academy of Pain Medicine; and Kevin Galloway, BSN, MHA, Colonel, US Army (Retired), Board member, Academy of Integrative Pain Management.

A concept outline will be shared in advance of the first meeting to be held on Wednesday, April 18, 2018 from 2-3 PST / 3-4 MST / 4-5 CST / 5-6 EST.  Monthly meetings will occur at the same time on the 3rd Wednesday of each month.

View the roster of participants for Promoting Comprehensive, Integrative Pain Care.

Strategic Communication. This group will begin with developing  easy-to-access documents with a consistent look and feel to effectively communicate and build momentum around common language and other outputs, starting with 1) further endorsements of the consensus definition of comprehensive, integrative pain care developed at our first meeting (many of your organizations already have endorsed this); 2) creation of a more robust Integrative Pain Care Policy Congress Blog; and 3) organizing and communicating effectively around the second in-person Integrative Pain Care Policy Congress being planned for November 2018 (announcement coming soon!)  Co-faciliators are Cindy Leyland, Director of Program Operations and PAINS Project Manager for Center for Practical Bioethics; and James Specker, Government & Industry Relations Director, American Massage Therapy Association.

A concept outline will be shared in advance of the first meeting to be held on Tuesday, April 10, 2018 from 11-12 PST / 12-1 MST / 1-2 CST / 2-3 EST.  Monthly meetings will occur at the same time on the 2nd Tuesday of each month.

View the roster of participants for Strategic Communication.

This post has not been tagged.

Share |
PermalinkComments (0)
 

Federal Government Continues Its Deep Look at Integrative Pain Care

Posted By Katie Duensing, Monday, March 12, 2018

In a flurry of activity that would have shocked the integrative pain care community just a few years ago, the federal government, at both the legislative and administrative levels, continues to take a deep look at how non-opioid and non-pharmacological treatments for pain can be better utilized to treat pain and reduce reliance on opioid analgesics.

Congress Asks for Advice Related to Pain Management, Alternatives to Opioids

As we mentioned last month, the Senate Finance Committee recently sought out comments related to how Medicare and Medicaid program incentives can be used for beneficiaries with chronic pain in ways that minimize the risk of becoming addicted to opioids. In response, two members of the Integrative Pain Care Policy Congress, AIPM and US Pain Foundation, submitted a joint letter to the committee recommending a long list of steps that CMS could take to remove barriers to high quality integrative pain care and improve data collection related to that type of care.

Following on the Senate committee’s heels, on February 27th, the House Ways and Means Committee sent a letter seeking feedback from a variety of stakeholders, asking a long list of questions related to opioids and pain management. The committee wants information related to incentives in Medicare, tools to prevent opioid abuse, medication therapy management, prescriber education, prescription monitoring programs, reimbursement, alternative options for the treatment of pain, and more. Comments are due no later than March 15, 2018.

CMS Proposes New Payment Policies, Asks for Advice re: Non-Pharmacological Interventions

Apart from the two legislative bodies responsible for overseeing CMS (both committees mentioned above), CMS itself recently asked for public comments related to their proposed payment policies for 2019. In addition to proposing new payment structures related to opioids, the proposed policy also stated that, “CMS and measure developers are exploring additional measurement concepts for future work, such as functional status, and use of non-pharmacological or non-opioid pain management interventions…” In response, AIPM submitted comments related to both limitations on opioids and the use of non-pharmacological and/or non-opioid pain management interventions.

CARA 2.0 Act of 2018

The second iteration of the Comprehensive Addiction and Recovery Act, or CARA 2.0, has been introduced by the Senate Health, Education, Labor & Pensions (HELP) Committee. The legislation is intended to make improvements to the original CARA, and while the bill-as-introduced is lacking in certain pain provisions, Senate leadership from HELP and Finance Committees have expressed their openness to the inclusion of pain-related provisions. Forty-two organizations, including numerous members of the Integrative Pain Care Policy Congress, have signed on to a document outlining what they would like to see included in the legislation related to pain. The House is also working on their own version of this legislation, and there will be a few substantive hearings later this month. More details to come soon. 

Application Deadline for CMS Bundled Payments is March 12

As shared in a previous update, if you are interested in applications for the Bundled Payments for Care Improvement Advanced (BPCI Advanced) model, the application deadline is March 12, 2018.  More information about this process can be found here.

Integrative Pain Care Policy Congress Next Steps

The Integrative Pain Care Policy Congress continues to make progress in working together to advance integrative pain care. Based on survey results, the Congress is launching three new workgroups: (1) Coverage and Constraints, (2) Promoting Comprehensive, Integrative Pain Care, and (3) Strategic Communication. In the surveys that helped to form these workgroups, participants also indicated their interest in helping above and beyond meeting participation and with the strategic direction of these workgroups. On that note, Workgroup leadership will be meeting by phone on March 19-20, so you can expect to hear more about these workgroups next month!

This post has not been tagged.

Share |
PermalinkComments (0)
 
Page 1 of 2
1  |  2